Back
Regeneron Pharmaceuticals Stock Predictions
Sponsored
REGN
Sponsored
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
42
REGN
Regeneron Pharmaceuticals
Last Price:
$701.91
Seasonality Move:
10.8%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Regeneron Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 31% based on the past 33 years of stock performance.
-
Regeneron Pharmaceuticals has risen higher in 20 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 60.61%
-
Is Regeneron Pharmaceuticals Stock Undervalued?The current Regeneron Pharmaceuticals [REGN] share price is $701.85. The Score for REGN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
REGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Regeneron Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 31% based on the past 33 years of stock performance.
Regeneron Pharmaceuticals Stock Rating
Sell
42
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals overpriced?
-
Regeneron Pharmaceuticals has risen higher in 20 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 60.61%
Regeneron Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
regeneron.com
52-Week Data
52-Week High:
1,211.20
52-Week Low:
693.00
Prediction Charts
Market Cap:
77.1B
Price in USD:
701.85
Volume:
1.9M
Beta:
0.95
Technical Analysis
SMA50:
826.21
SMA100:
972.69
SMA200:
980.92
52-Wk Change:
-16.62%
Stock Predictions
-
Is Regeneron Pharmaceuticals stock public?Yes, Regeneron Pharmaceuticals is a publicly traded company.
-
What is the Regeneron Pharmaceuticals stock quote today?The Regeneron Pharmaceuticals stock price is 701.85 USD today.
-
How to buy Regeneron Pharmaceuticals stock online?You can buy Regeneron Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Dec-3 | 758.53 | 749.57 | 770.00 | 747.57 |
Dec-4 | 748.56 | 754.26 | 756.13 | 744.14 |
Dec-5 | 751.55 | 767.90 | 768.02 | 749.69 |
Dec-6 | 768.64 | 778.00 | 778.12 | 765.16 |
Dec-9 | 777.00 | 788.00 | 800.99 | 773.00 |
Dec-10 | 784.10 | 778.50 | 791.49 | 762.70 |
Dec-11 | 778.15 | 773.00 | 781.32 | 766.87 |
Dec-12 | 773.12 | 740.97 | 778.73 | 740.46 |
Dec-13 | 738.45 | 731.30 | 740.17 | 728.68 |
Dec-16 | 730.52 | 724.87 | 739.39 | 722.23 |
Dec-17 | 721.37 | 740.01 | 744.80 | 721.08 |
Dec-18 | 735.21 | 714.62 | 745.00 | 712.30 |
Dec-19 | 711.00 | 708.25 | 714.05 | 693.00 |
Dec-20 | 710.20 | 701.85 | 717.61 | 700.83 |
Regeneron Pharmaceuticals Earnings
Regeneron Pharmaceuticals Earnings Report: Per Share Regeneron Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Regeneron Pharmaceuticals Forecast Revenue Growth
Regeneron Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Regeneron Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $2.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.58 per share, and a decrease next year of $0.14 per share.
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.